| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |